SGLT2 Inhibitor Plus MRA Further Reduces Albuminuria
Study findings indicate synergistic effects of SGLT2 inhibitors and MRAs on albuminuria.
Diagnosis & Disease Information
Diabetic Kidney Disease in US Veterans Characterized
The prevalence of diabetic kidney disease is higher among US veterans than the general population, investigators noted.
Finerenone May Provide Cardiovascular Benefits in Stage 4 Diabetic Kidney Disease
Patients with stage 4 diabetic kidney disease are understudied and lack treatment options.
GLP-1RAs Offer Better Renoprotection in Advanced Diabetic Kidney Disease
Previous GLP-1RA trials have mostly excluded patients with advanced diabetic kidney disease.
Kidney Biopsy Findings Predict Risk of Cardiovascular Events in CKD
Histologic lesions in the kidney may reflect systemic processes that lead to cardiovascular events, according to investigators.
Glycated Albumin to HbA1c Ratio Predicts Death in Dialysis Population With Diabetes
The ratio is a clinically meaningful indicator that is easily obtained from blood test results, according to investigators.
Triglyceride-Glucose Index Predicts Hyperuricemia in Diabetic Kidney Disease
Early identification of patients at high risk of hyperuricemia using the triglyceride-glucose index may permit prompt intervention.
Personalized Screening for Kidney Disease Evaluated in Type 1 Diabetes
Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency
Kidney Function Declines More Slowly With SGLT2 Inhibitor
Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.
Finerenone May Protect Against Pneumonia and COVID-19
Finerenone, a mineralocorticoid receptor antagonist, may exert anti-inflammatory and anti-fibrotic effects, according to investigators.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...